The 8.1 ancestral MHC haplotype is associated with delayed onset of colonization in cystic fibrosis

International Immunology

Volumn 18, Issue 11, 2006, Pages 1585-1590

  Laki, Judit ^a,b   Laki, István ^c   Németh, Krisztina ^a   Újhelyi, Rita ^d   Bede, Olga ^e   Endreffy, Emoke ^e   Bolbás, Katalin ^c   Gyurkovits, Kálmán ^c   Csiszér, Eszter ^f   Sólyom, Eniko ^g   Dobra, Gergely ^c   Halász, Adrienn ^h   Pozsonyi, Éva ⁱ   Rajczy, Katalin ⁱ   Prohászka, Zoltán ^a,b   Fekete, György ^a   Füst, George ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c Hospital for Chest Diseases   (Hungary)

^d HEIM PÁL CHILDREN S HOSPITAL   (Hungary)

^e UNIVERSITY OF SZEGED   (Hungary)

^f NATIONAL KORANYI INSTITUTE OF PULMONOLOGY   (Hungary)

^g University Teaching Hospital   (Hungary)

^h Svabhegy Children's Hospital   (Hungary)

ⁱ NATIONAL MEDICAL CENTER   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; DNA; HEAT SHOCK PROTEIN 70; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; TRANSMEMBRANE CONDUCTANCE REGULATOR; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ALLELE; ARTICLE; BACTERIAL COLONIZATION; CAUSE OF DEATH; CHILD; CHROMOSOME 6; CHROMOSOME ARM; CLINICAL EXAMINATION; CONTROLLED STUDY; CYSTIC FIBROSIS; DATA ANALYSIS; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MICROBIOLOGICAL EXAMINATION; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STATISTICAL ANALYSIS; SURVIVAL;

ADOLESCENT; ADULT; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DISEASE SUSCEPTIBILITY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA ANTIGENS; HUMANS; HUNGARY; INFANT; POLYMORPHISM, GENETIC; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 33750214382     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxl091     Document Type: Article

References (31)

1. Ratjen, F. and Doring, G. 2003. Cystic fibrosis. Lancet 361:681.
2. Koch, C. and Hoiby, N. 1993. Pathogenesis of cystic fibrosis. Lancet 341:1065.
3. Davies, J. C., Griesenbach, U. and Alton, E. 2005. Modifier genes in cystic fibrosis. Pediatr. Pulmonol. 39:383.
4. Acton, J. D. and Wilmott, R. W. 2001. Phenotype of CF and the effects of possible modifier genes. Paediatr. Respir. Rev. 2:332.
5. Lester, L. A., Kraut, J., Lloyd-Still, J. et al. 1994. Delta F508 genotype does not predict disease severity in an ethnically diverse cystic fibrosis population. Pediatrics 93:114.
6. Hull, J. and Thomson, A. H. 1998. Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis. Thorax 53:1018.
7. Yarden, J., Radojkovic, D., De Boeck, K. et al. 2005. Association of tumour necrosis factor alpha variants with the CF pulmonary phenotype. Thorax 60:320.
8. Arkwright, P. D., Pravica, V., Geraghty, P. J. et al. 2003. End-organ dysfunction in cystic fibrosis: Association with angiotensin I converting enzyme and cytokine gene polymorphisms. Am. J. Respir. Crit. Care Med. 167:384.
9. The Cystic Fibrosis Genotype-Phenotype Consortium. 1993. Correlation between genotype and phenotype in patients with cystic fibrosis. N. Engl. J. Med. 329:1308.
10. Burke,W., Aitken, M. L., Chen, S. H. and Scott, C. R. 1992. Variable severity of pulmonary disease in adults with identical cystic fibrosis mutations. Chest 102:506.
11. Arkwright, P. D., Laurie, S., Super, M. et al. 2000. TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis. Thorax 55:459.
12. Garred, P., Pressler, T., Madsen, H. O. et al. 1999. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J. Clin. Invest. 104:431.
13. Gabolde, M., Guilloud-Bataille, M., Feingold, J. and Besmond, C. 1999. Association of variant alleles of mannose binding lectin with severity of pulmonary disease in cystic fibrosis: Cohort study. Br. Med. J. 319:1166.
14. Texereau, J., Marullo, S., Hubert, D. et al. 2004. Nitric oxide synthase 1 as a potential modifier gene of decline in lung function in patients with cystic fibrosis. Thorax 59:156.
15. Aron, Y., Polla, B. S., Bienvenu, T. et al. 1999. HLA class II polymorphism in cystic fibrosis. A possible modifier of pulmonary phenotype. Am. J. Respir. Crit. Care Med. 159:1464.
16. Duthie, A., Doherty, D. G., Donaldson, P. T. et al. 1995. The major histocompatibility complex influences the development of chronic liver disease in male children and young adults with cystic fibrosis. J. Hepatol. 23:532.
17. Rubin, B. K. 1990. Exposure of children with cystic fibrosis to environmental tobacco smoke. N. Engl. J. Med. 323:782.
18. Price, P., Witt, C., Allcock, R. et al. 1999. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol. Rev. 167:257.
19. Tay, G. K., Cattley, S. K., Chorney, M. J. et al. 1997. Conservation of ancestral haplotypes telomeric of HLA-A. Eur. J. Immunogenet. 24:275.
20. Caruso, C., Candore, G., Colonna Romano, G. et al. 2000. HLA, aging, and longevity: A critical reappraisal. Hum. Immunol. 61:942.
21. Candore, G., Modica, M. A., Lio, D. et al. 2003. Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: A genetically determined defect of C4 influences immunological parameters of healthy carriers of the haplotype. Biomed. Pharmacother. 57:274.
22. Ahmad, T., Armuzzi, A., Neville, M. et al. 2003. The contribution of human leucocyte antigen complex genes to disease phenotype in ulcerative colitis. Tissue Antigens 62:527.
23. Hudson, B. I., Stickland, M. H., Futers, T. S. and Grant, P. J. 2001. Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes 50:1505.
24. Vargas-Alarcon, G., Londono, J. D., Hernandez-Pacheco, G. et al. 2002. Heat shock protein 70 gene polymorphisms in Mexican patients with spondyloarthropathies. Ann. Rheum. Dis. 61:48.
25. Schroeder, S., Reck, M., Hoeft, A. and Stuber, F. 1999. Analysis of two human leukocyte antigen-linked polymorphic heat shock protein 70 genes in patients with severe sepsis. Crit. Care Med. 27:1265.
26. De Rose, V., Arduino, C., Cappello, N. et al. 2005. Fcgamma receptor IIA genotype and susceptibility to P. aeruginosa infection in patients with cystic fibrosis. Eur. J. Hum. Genet. 13:96.
27. Lang, A. B., Horn, M. P., Imboden, M. A. and Zuercher, A. W. 2004. Prophylaxis and therapy of Pseudomonas aeruginosa infection in cystic fibrosis and immunocompromised patients. Vaccine 22(Suppl. 1):S44.
28. Degli-Esposti, M. A., Leaver, A. L., Christiansen, F. T. et al. 1992. Ancestral haplotypes: Conserved population MHC haplotypes. Hum. Immunol. 34:242.
29. Slieker, M. G., Sanders, E. A., Rijkers, G. T., Ruven, H. J. and van der Ent, C. K. 2005. Disease modifying genes in cystic fibrosis. J. Cyst. Fibros. 4(Suppl. 2):7.
30. Bobadilla, J. L., Macek, M., Jr, Fine, J. P. and Farrell, P. M. 2002. Cystic fibrosis: A worldwide analysis of CFTR mutations - correlation with incidence data and application to screening. Hum. Mutat. 19:575.
31. Candore, G., Lio, D., Colonna Romano, G. and Caruso, C. 2002. Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: Effect of multiple gene interactions. Autoimmun. Rev. 1:29.